NCT04852666View on ClinicalTrials.gov

Comparative Effectiveness of Biologics or Small Molecule Therapies in Inflammatory Bowel Disease (IBD)

CompletedOBSERVATIONAL
Enrollment

465

Participants

Timeline

Start Date

July 25, 2019

Primary Completion Date

December 15, 2022

Study Completion Date

December 15, 2022

Conditions
Crohn's DiseaseUlcerative Colitis
Trial Locations (2)

10017

Crohn's & Colitis Foundation, New York

27599-7555

University of North Carolina, Chapel Hill

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

collaborator

Crohn's and Colitis Foundation

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT04852666 - Comparative Effectiveness of Biologics or Small Molecule Therapies in Inflammatory Bowel Disease (IBD) | Biotech Hunter | Biotech Hunter